{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:18:33Z","timestamp":1789935513820,"version":"4.0.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T00:00:00Z","timestamp":1364428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00198-013-2335-4","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T09:29:41Z","timestamp":1364376581000},"page":"2737-2748","source":"Crossref","is-referenced-by-count":34,"title":["The role of the gastrointestinal tract in calcium homeostasis and bone remodeling"],"prefix":"10.1007","volume":"24","author":[{"given":"J.","family":"Keller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Schinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,28]]},"reference":[{"key":"2335_CR1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature10763","volume":"481","author":"G Karsenty","year":"2012","unstructured":"Karsenty G, Ferron M (2012) The contribution of bone to whole-organism physiology. Nature 481:314\u2013320","journal-title":"Nature"},{"key":"2335_CR2","doi-asserted-by":"crossref","unstructured":"Howgate DJ, Graham SM, Leonidou A, Korres N, Tsiridis E, Tsapakis E (2013) Bone metabolism in anorexia nervosa: molecular pathways and current treatment modalities. Osteoporos Int 24:407\u2013421","DOI":"10.1007\/s00198-012-2095-6"},{"key":"2335_CR3","doi-asserted-by":"crossref","first-page":"G191","DOI":"10.1152\/ajpgi.00496.2010","volume":"300","author":"FK Ghishan","year":"2011","unstructured":"Ghishan FK, Kiela PR (2011) Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol 300:G191\u2013201","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2335_CR4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/PHAR.1007","volume":"32","author":"YT Lau","year":"2012","unstructured":"Lau YT, Ahmed NN (2012) Fracture risk and bone mineral density reduction associated with proton pump inhibitors. Pharmacotherapy 32:67\u201379","journal-title":"Pharmacotherapy"},{"key":"2335_CR5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.annepidem.2004.11.002","volume":"15","author":"K Aoki","year":"2005","unstructured":"Aoki K, Kihaile PE, Wenyuan Z, Xianghang Z, Castro M, Disla M, Nyambo TB, Misumi J (2005) Comparison of prevalence of chronic atrophic gastritis in Japan, China, Tanzania, and the Dominican Republic. Ann Epidemiol 15:598\u2013606","journal-title":"Ann Epidemiol"},{"key":"2335_CR6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3109\/00365529609009126","volume":"31","author":"J Valle","year":"1996","unstructured":"Valle J, Kekki M, Sipponen P, Iham\u00e4ki T, Siurala M (1996) Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 31:546\u2013550","journal-title":"Scand J Gastroenterol"},{"key":"2335_CR7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/00365529109103982","volume":"186","author":"T Iham\u00e4ki","year":"1991","unstructured":"Iham\u00e4ki T, Sipponen P, Varis K, Kekki M, Siurala M (1991) Characteristics of gastric mucosa which precede occurrence of gastric malignancy: results of long-term follow-up of three family samples. Scand J Gastroenterol 186:16\u201323","journal-title":"Scand J Gastroenterol"},{"key":"2335_CR8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11926-008-0017-6","volume":"10","author":"ZA Cole","year":"2008","unstructured":"Cole ZA, Dennison EM, Cooper C (2008) Osteoporosis epidemiology update. Curr Rheumatol Rep 10:92\u201396","journal-title":"Curr Rheumatol Rep"},{"key":"2335_CR9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0092-8674(04)00344-7","volume":"117","author":"X Yang","year":"2004","unstructured":"Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, Karsenty G (2004) ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology: implication for Coffin\u2013Lowry syndrome. Cell 117:387\u2013398","journal-title":"Cell"},{"key":"2335_CR10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2006.10.010","volume":"4","author":"F Elefteriou","year":"2006","unstructured":"Elefteriou F, Benson MD, Sowa H, Starbuck M, Liu X, Ron D, Parada LF, Karsenty G (2006) ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab 4:441\u2013451","journal-title":"Cell Metab"},{"issue":"4","key":"2335_CR11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","volume":"107","author":"Y Gong","year":"2001","unstructured":"Gong Y et al (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107(4):513\u2013523","journal-title":"Cell"},{"key":"2335_CR12","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","volume":"346","author":"LM Boyden","year":"2002","unstructured":"Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513\u20131521","journal-title":"N Engl J Med"},{"key":"2335_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/338450","volume":"70","author":"RD Little","year":"2002","unstructured":"Little RD et al (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11\u201319","journal-title":"Am J Hum Genet"},{"key":"2335_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2011.10.044","volume":"492","author":"DG Monroe","year":"2012","unstructured":"Monroe DG, McGee-Lawrence ME, Oursler MJ, Westendorf JJ (2012) Update on Wnt signaling in bone cell biology and bone disease. Gene 492:1\u201318","journal-title":"Gene"},{"key":"2335_CR15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","volume":"135","author":"VK Yadav","year":"2008","unstructured":"Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Sch\u00fctz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, Mann JJ, Hen R, Ducy P, Karsenty G (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135:825\u2013837","journal-title":"Cell"},{"key":"2335_CR16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2388","volume":"17","author":"Y Cui","year":"2011","unstructured":"Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N, Robinson DR, Zhong Z, Matthes S, Jacobsen CM, Conlon RA, Brommage R, Liu Q, Mseeh F, Powell DR, Yang QM, Zambrowicz B, Gerrits H, Gossen JA, He X, Bader M, Williams BO, Warman ML, Robling AG (2011) Lrp5 functions in bone to regulate bone mass. Nat Med 17:684\u2013691","journal-title":"Nat Med"},{"key":"2335_CR17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(97)09528-7","volume":"351","author":"B Liu","year":"1998","unstructured":"Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N (1998) Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351:1303\u20131307","journal-title":"Lancet"},{"key":"2335_CR18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archinte.167.2.188","volume":"167","author":"JB Richards","year":"2007","unstructured":"Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC, Goltzman D, Canadian Multicentre Osteoporosis Study Research Group (2007) Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167:188\u2013194","journal-title":"Arch Intern Med"},{"key":"2335_CR19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00198-011-1778-8","volume":"23","author":"Q Wu","year":"2012","unstructured":"Wu Q, Bencaz AF, Hentz JG, Crowell MD (2012) Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case\u2013control studies. Osteoporos Int 23:365\u2013375","journal-title":"Osteoporos Int"},{"key":"2335_CR20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bone.2012.05.018","volume":"51","author":"R Rizzoli","year":"2012","unstructured":"Rizzoli R, Cooper C, Reginster JY, Abrahamsen B, Adachi JD, Brandi ML, Bruy\u00e8re O, Compston J, Ducy P, Ferrari S, Harvey NC, Kanis JA, Karsenty G, Laslop A, Rabenda V, Vestergaard P (2012) Antidepressant medications and osteoporosis. Bone 51:606\u2013613","journal-title":"Bone"},{"key":"2335_CR21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1749-6632.2009.05226.x","volume":"1192","author":"D Goltzman","year":"2010","unstructured":"Goltzman D (2010) Vitamin D action: lessons learned from genetic mouse models. Ann N Y Acad Sci 1192:145\u2013152","journal-title":"Ann N Y Acad Sci"},{"key":"2335_CR22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1152\/physrev.1986.66.4.855","volume":"66","author":"PJ Nijweide","year":"1986","unstructured":"Nijweide PJ, Burger EH, Feyen JHM (1986) Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol Rev 66:855\u2013886","journal-title":"Physiol Rev"},{"key":"2335_CR23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1023\/A:1006803615430","volume":"24","author":"GS Stein","year":"1997","unstructured":"Stein GS, Lian JB, van Wijnen AJ, Stein JL (1997) The osteocalcin gene: a model for multiple parameters of skeletal-specific transcriptional control. Mol Biol Rep 24:185\u2013196","journal-title":"Mol Biol Rep"},{"key":"2335_CR24","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1210\/endo-128-3-1496","volume":"128","author":"TA Owen","year":"1999","unstructured":"Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB (1999) Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128:1496\u20131504","journal-title":"Endocrinology"},{"key":"2335_CR25","doi-asserted-by":"crossref","unstructured":"Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB (1998) Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139:4391\u20134396","DOI":"10.1210\/en.139.10.4391"},{"key":"2335_CR26","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1210\/en.140.11.4982","volume":"140","author":"M Amling","year":"1999","unstructured":"Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB (1999) Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140:4982\u20134987","journal-title":"Endocrinology"},{"key":"2335_CR27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0022-3476(05)81919-5","volume":"121","author":"Z Hochberg","year":"1992","unstructured":"Hochberg Z, Tiosano D, Even L (1992) Calcium therapy for calcitriol-resistant rickets. J Pediatr 121:803\u2013808","journal-title":"J Pediatr"},{"key":"2335_CR28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/1043-2760(95)00126-3","volume":"6","author":"Z Hochberg","year":"1995","unstructured":"Hochberg Z, Weisman Y (1995) Calcitriol-resistant rickets due to vitamin D receptor defects. Trends Endocrinol Metab 6:216\u2013220","journal-title":"Trends Endocrinol Metab"},{"key":"2335_CR29","first-page":"801","volume":"34","author":"BC Silva","year":"2011","unstructured":"Silva BC, Costa AG, Cusano NE, Kousteni S, Bilezikian JP (2011) Catabolic and anabolic actions of parathyroid hormone on the skeleton. J Endocrinol Invest 34:801\u2013810","journal-title":"J Endocrinol Invest"},{"key":"2335_CR30","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJM200304103481521","volume":"348","author":"CJ Rosen","year":"2003","unstructured":"Rosen CJ, Brown S (2003) Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med 348:1503\u20131504","journal-title":"N Engl J Med"},{"key":"2335_CR31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4158\/EP.12.1.48","volume":"12","author":"NM Maalouf","year":"2006","unstructured":"Maalouf NM, Heller HJ, Odvina CV, Kim PJ, Sakhaee K (2006) Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature. Endocr Pract 12:48\u201353","journal-title":"Endocr Pract"},{"key":"2335_CR32","doi-asserted-by":"crossref","unstructured":"Liamis G, Milionis HJ, Elisaf M (2009) A review of drug-induced hypocalcemia. J Bone Miner Metab 27:635\u2013642","DOI":"10.1007\/s00774-009-0119-x"},{"key":"2335_CR33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00003086-199309000-00008","volume":"294","author":"FS Kaplan","year":"1993","unstructured":"Kaplan FS, August CS, Fallon MD, Gannon F, Haddad JG (1993) Osteopetrorickets. The paradox of plenty. Pathophysiology and treatment. Clin Orthop Relat Res 294:64\u201378","journal-title":"Clin Orthop Relat Res"},{"key":"2335_CR34","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1056\/NEJMra040952","volume":"351","author":"J Tolar","year":"2004","unstructured":"Tolar J, Teitelbaum SL, Orchard PJ (2004) Osteopetrosis. N Engl J Med 351:2839\u20132849","journal-title":"N Engl J Med"},{"key":"2335_CR35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/70563","volume":"23","author":"YP Li","year":"1999","unstructured":"Li YP, Chen W, Liang Y, Li E, Stashenko P (1999) Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet 23:447\u2013451","journal-title":"Nat Genet"},{"key":"2335_CR36","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00003086-198512000-00036","volume":"201","author":"R Banco","year":"1985","unstructured":"Banco R, Seifert MF, Marks SC Jr, McGuire JL (1985) Rickets and osteopetrosis: the osteosclerotic (OC) mouse. Clin Orthop Relat Res 201:238\u2013246","journal-title":"Clin Orthop Relat Res"},{"key":"2335_CR37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/77131","volume":"25","author":"A Frattini","year":"2000","unstructured":"Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK, Wallbrandt P, Zecca L, Notarangelo LD, Vezzoni P, Villa A (2000) Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 25:343\u2013346","journal-title":"Nat Genet"},{"key":"2335_CR38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9440(10)63798-4","volume":"162","author":"A Taranta","year":"2003","unstructured":"Taranta A, Migliaccio S, Recchia I, Caniglia M, Luciani M, De Rossi G, Dionisi-Vici C, Pinto RM, Francalanci P, Boldrini R, Lanino E, Dini G, Morreale G, Ralston SH, Villa A, Vezzoni P, Del Principe D, Cassiani F, Palumbo G, Teti A (2003) Genotype\u2013phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am J Pathol 162:57\u201368","journal-title":"Am J Pathol"},{"key":"2335_CR39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jmg.2005.036673","volume":"43","author":"A Fattore Del","year":"2006","unstructured":"Del Fattore A, Peruzzi B, Rucci N, Recchia I, Cappariello A, Longo M, Fortunati D, Ballanti P, Iacobini M, Luciani M, Devito R, Pinto R, Caniglia M, Lanino E, Messina C, Cesaro S, Letizia C, Bianchini G, Fryssira H, Grabowski P, Shaw N, Bishop N, Hughes D, Kapur RP, Datta HK, Taranta A, Fornari R, Migliaccio S, Teti A (2006) Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet 43:315\u2013325","journal-title":"J Med Genet"},{"key":"2335_CR40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nm.1963","volume":"15","author":"T Schinke","year":"2009","unstructured":"Schinke T, Schilling AF, Baranowsky A, Seitz S, Marshall RP, Linn T, Blaeker M, Huebner AK, Schulz A, Simon R, Gebauer M, Priemel M, Kornak U, Perkovic S, Barvencik F, Beil FT, Del Fattore A, Frattini A, Streichert T, Pueschel K, Villa A, Debatin KM, Rueger JM, Teti A, Zustin J, Sauter G, Amling M (2009) Impaired gastric acidification negatively affects calcium homeostasis and bone mass. Nat Med 15:674\u2013681","journal-title":"Nat Med"},{"key":"2335_CR41","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-66-5-917","volume":"66","author":"P Ivanovich","year":"1967","unstructured":"Ivanovich P, Fellows H, Rich C (1967) The absorption of calcium carbonate. Ann Intern Med 66:917\u2013923","journal-title":"Ann Intern Med"},{"key":"2335_CR42","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0016-5085(97)90000-7","volume":"112","author":"N Langhans","year":"1997","unstructured":"Langhans N, Rindi G, Chiu M, Rehfeld JF, Ardman B, Beinborn M, Kopin AS (1997) Abnormal gastric histology and decreased acid production in cholecystokinin-B\/gastrin receptor-deficient mice. Gastroenterology 112:280\u2013286","journal-title":"Gastroenterology"},{"key":"2335_CR43","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/gut.32.11.1298","volume":"32","author":"J Axelson","year":"1991","unstructured":"Axelson J, Persson P, Gagnemo-Persson R, H\u00e5kanson R (1991) Importance of the stomach in maintaining calcium homoeostasis in the rat. Gut 32:1298\u20131302","journal-title":"Gut"},{"key":"2335_CR44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00000658-199702000-00006","volume":"225","author":"GW Maier","year":"1997","unstructured":"Maier GW, Kreis ME, Zittel TT, Becker HD (1997) Calcium regulation and bone mass loss after total gastrectomy in pigs. Ann Surg 225:181\u2013192","journal-title":"Ann Surg"},{"key":"2335_CR45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0016-5085(99)70453-1","volume":"117","author":"KL Scarff","year":"1999","unstructured":"Scarff KL, Judd LM, Toh BH, Gleeson PA, Van Driel IR (1999) Gastric H(+), K(+)-adenosine triphosphatase beta subunit is required for normal function, development, and membrane structure of mouse parietal cells. Gastroenterology 117:605\u2013618","journal-title":"Gastroenterology"},{"key":"2335_CR46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jcb.23337","volume":"113","author":"R Fossmark","year":"2011","unstructured":"Fossmark R, Stunes AK, Petzold C, Waldum HL, Rubert M, Lian AM, Reseland JE, Syversen U (2011) Decreased bone mineral density and reduced bone quality in H+\/K+ ATPase beta-subunit deficient mice. J Cell Biochem 113:141\u2013147","journal-title":"J Cell Biochem"},{"key":"2335_CR47","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/003655201750422585","volume":"36","author":"GL Cui","year":"2001","unstructured":"Cui GL, Syversen U, Zhao CM, Chen D, Waldum HL (2001) Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats. Scand J Gastroenterol 36:1011\u20131015","journal-title":"Scand J Gastroenterol"},{"key":"2335_CR48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.nu.09.070189.001415","volume":"9","author":"Z Kassarjian","year":"1989","unstructured":"Kassarjian Z, Russell RM (1989) Hypochlorhydria: a factor in nutrition. Annu Rev Nutr 9:271\u2013285","journal-title":"Annu Rev Nutr"},{"key":"2335_CR49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11894-001-0072-x","volume":"3","author":"EJ Kuipers","year":"2001","unstructured":"Kuipers EJ, Grool TA (2001) The dynamics of gastritis. Curr Gastroenterol Rep 3:509\u2013515","journal-title":"Curr Gastroenterol Rep"},{"key":"2335_CR50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/00365520903434117","volume":"45","author":"P Sipponen","year":"2010","unstructured":"Sipponen P, H\u00e4rk\u00f6nen M (2010) Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis? Scand J Gastroenterol 45:133\u2013138","journal-title":"Scand J Gastroenterol"},{"key":"2335_CR51","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.drudis.2009.03.014","volume":"14","author":"JM Mullin","year":"2009","unstructured":"Mullin JM, Gabello M, Murray LJ, Farrell CP, Bellows J, Wolov KR, Kearney KR, Rudolph D, Thornton JJ (2009) Proton pump inhibitors: actions and reactions. Drug Discov Today 14:647\u2013660","journal-title":"Drug Discov Today"},{"key":"2335_CR52","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0016-5085(00)70004-7","volume":"118","author":"MM Wolfe","year":"2000","unstructured":"Wolfe MM, Sachs G (2000) Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology 118:S9\u201331","journal-title":"Gastroenterology"},{"key":"2335_CR53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3949\/ccjm.77a.10087","volume":"78","author":"RD Madanick","year":"2011","unstructured":"Madanick RD (2011) Proton pump inhibitor side effects and drug interactions: much ado about nothing? Cleve Clin J Med 78:39\u201349","journal-title":"Cleve Clin J Med"},{"key":"2335_CR54","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10620-010-1560-3","volume":"56","author":"E Sheen","year":"2011","unstructured":"Sheen E, Triadafilopoulos G (2011) Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci 56:931\u2013950","journal-title":"Dig Dis Sci"},{"key":"2335_CR55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00223-008-9170-1","volume":"83","author":"EW Yu","year":"2008","unstructured":"Yu EW, Blackwell T, Ensrud KE, Hillier TA, Lane NE, Orwoll E, Bauer DC (2008) Acid-suppressive medications and risk of bone loss and fracture in older adults. Calcif Tissue Int 83:251\u2013259","journal-title":"Calcif Tissue Int"},{"key":"2335_CR56","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archinternmed.2010.94","volume":"170","author":"SL Gray","year":"2010","unstructured":"Gray SL, LaCroix AZ, Larson J, Robbins J, Cauley JA, Manson JE, Chen Z (2010) Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women\u2019s Health Initiative. Arch Intern Med 170:765\u2013771","journal-title":"Arch Intern Med"},{"key":"2335_CR57","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/j.gastro.2009.11.014","volume":"138","author":"LE Targownik","year":"2010","unstructured":"Targownik LE, Lix LM, Leung S, Leslie WD (2010) Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. Gastroenterology 138:896\u2013904","journal-title":"Gastroenterology"},{"key":"2335_CR58","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","volume":"296","author":"YX Yang","year":"2006","unstructured":"Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296:2947\u20132953","journal-title":"JAMA"},{"key":"2335_CR59","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00223-006-0021-7","volume":"79","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006) Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int 79:76\u201383","journal-title":"Calcif Tissue Int"},{"key":"2335_CR60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/j.gastro.2010.03.055","volume":"139","author":"DA Corley","year":"2010","unstructured":"Corley DA, Kubo A, Zhao W, Quesenberry C (2010) Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology 139:93\u2013101","journal-title":"Gastroenterology"},{"key":"2335_CR61","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2011.01.007","volume":"124","author":"EW Yu","year":"2011","unstructured":"Yu EW, Bauer SR, Bain PA, Bauer DC (2011) Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med 124:519\u2013526","journal-title":"Am J Med"},{"key":"2335_CR62","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1136\/bmj.e372","volume":"344","author":"H Khalili","year":"2012","unstructured":"Khalili H, Huang ES, Jacobson BC, Camargo CA Jr, Feskanich D, Chan AT (2012) Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. BMJ 344:e372. doi: 10.1136\/bmj.e372","journal-title":"BMJ"},{"key":"2335_CR63","doi-asserted-by":"crossref","unstructured":"Fraser LA, Leslie WD, Targownik LE, Papaioannou A, Adachi JD, CaMos Research Group (2013) The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporos Int. doi: 10.1007\/s00198-012-2112-9","DOI":"10.1007\/s00198-012-2112-9"},{"key":"2335_CR64","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.bone.2010.12.015","volume":"48","author":"CS Kwok","year":"2011","unstructured":"Kwok CS, Yeong JK, Loke YK (2011) Meta-analysis: risk of fractures with acid-suppressing medication. Bone 48:768\u2013776","journal-title":"Bone"},{"key":"2335_CR65","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3748\/wjg.v16.i19.2323","volume":"16","author":"AB Thomson","year":"2010","unstructured":"Thomson AB, Sauve MD, Kassam N, Kamitakahara H (2010) Safety of the long-term use of proton pump inhibitors. World J Gastroenterol 16:2323\u20132330","journal-title":"World J Gastroenterol"},{"key":"2335_CR66","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0009-9236(95)90245-7","volume":"58","author":"BJ Gertz","year":"1995","unstructured":"Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Freeman A, Quan H, Lasseter KC, Mucklow JC, Porras AG (1995) Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther 58:288\u2013298","journal-title":"Clin Pharmacol Ther"},{"key":"2335_CR67","first-page":"998","volume":"171","author":"B Abrahamsen","year":"2011","unstructured":"Abrahamsen B, Eiken P, Eastell R (2011) Proton pump inhibitor use and the antifracture efficacy of alendronate. Arch Intern Med 171:998\u20131004","journal-title":"Arch Intern Med"},{"key":"2335_CR68","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00198-009-0891-4","volume":"20","author":"F Vries de","year":"2009","unstructured":"de Vries F, Cooper AL, Cockle SM, van Staa TP, Cooper C (2009) Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates. Osteoporos Int 20:1989\u20131998","journal-title":"Osteoporos Int"},{"key":"2335_CR69","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00198-011-1574-5","volume":"23","author":"C Roux","year":"2012","unstructured":"Roux C, Goldstein JL, Zhou X, Klemes A, Lindsay R (2012) Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors. Osteoporos Int 23:277\u2013284","journal-title":"Osteoporos Int"},{"key":"2335_CR70","unstructured":"FDA. http:\/\/www.fda.gov\/safety\/medwatch\/safetyinformation\/safetyalertsforhumanmedicalproducts\/ucm213321.htm . Accessed 6 January 2013"},{"key":"2335_CR71","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02556841","volume":"38","author":"J Tuukkanen","year":"1986","unstructured":"Tuukkanen J, V\u00e4\u00e4n\u00e4nen HK (1986) Omeprazole, a specific inhibitor of H+\u2212K+-ATPase, inhibits bone resorption in vitro. Calcif Tissue Int 38:123\u2013125","journal-title":"Calcif Tissue Int"},{"key":"2335_CR72","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0005-2736(91)90238-4","volume":"1065","author":"JP Mattsson","year":"1991","unstructured":"Mattsson JP, V\u00e4\u00e4n\u00e4nen K, Wallmark B, Lorentzon P (1991) Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases. Biochim Biophys Acta 1065:261\u2013268","journal-title":"Biochim Biophys Acta"},{"key":"2335_CR73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01352010","volume":"53","author":"K Mizunashi","year":"1993","unstructured":"Mizunashi K, Furukawa Y, Katano K, Abe K (1993) Effect of omeprazole, an inhibitor of H+, K(+)-ATPase, on bone resorption in humans. Calcif Tissue Int 53:21\u201325","journal-title":"Calcif Tissue Int"},{"key":"2335_CR74","doi-asserted-by":"crossref","unstructured":"Sharara AI, El-Halabi MM, Ghaith OA, Habib RH, Mansour NM, Malli A, El Hajj-Fuleihan G (2012) Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: a prospective matched controlled study. Metabolism. doi: 10.1016\/j.metabol.2012.09.011","DOI":"10.1016\/j.metabol.2012.09.011"},{"key":"2335_CR75","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ajg.2009.44","volume":"104","author":"K Insogna","year":"2009","unstructured":"Insogna K (2009) The effect of proton pump-inhibiting drugs on mineral metabolism. Am J Gastroenterol 104:S2\u20134","journal-title":"Am J Gastroenterol"},{"key":"2335_CR76","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.amjmed.2005.02.007","volume":"118","author":"MB O\u2019Connell","year":"2005","unstructured":"O\u2019Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ (2005) Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med 118:778\u2013781","journal-title":"Am J Med"},{"key":"2335_CR77","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM198507113130202","volume":"313","author":"RR Recker","year":"1985","unstructured":"Recker RR (1985) Calcium absorption and achlorhydria. N Engl J Med 313:70\u201373","journal-title":"N Engl J Med"},{"key":"2335_CR78","first-page":"1376","volume":"10","author":"G Graziani","year":"1995","unstructured":"Graziani G, Como G, Badalamenti S, Finazzi S, Malesci A, Gallieni M, Brancaccio D, Ponticelli C (1995) Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects. Nephrol Dial Transplant 10:1376\u20131380","journal-title":"Nephrol Dial Transplant"},{"key":"2335_CR79","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1525-1594.1998.06200.x","volume":"22","author":"P Hardy","year":"1998","unstructured":"Hardy P, Sechet A, Hottelart C, Oprisiu R, Abighanem O, Said S, Rasombololona M, Brazier M, Moriniere P, Achard JM, Pruna A, Fournier A (1998) Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis. Artif Organs 22:569\u2013573","journal-title":"Artif Organs"},{"key":"2335_CR80","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000064290","volume":"91","author":"G Graziani","year":"2002","unstructured":"Graziani G, Badalamenti S, Como G, Gallieni M, Finazzi S, Angelini C, Brancaccio D, Ponticelli C (2002) Calcium and phosphate plasma levels in dialysis patients after dietary Ca\u2013P overload. Role of gastric acid secretion. Nephron 91:474\u2013479","journal-title":"Nephron"},{"key":"2335_CR81","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/07315724.1995.10718522","volume":"14","author":"C Serfaty-Lacrosniere","year":"1995","unstructured":"Serfaty-Lacrosniere C, Wood RJ, Voytko D, Saltzman JR, Pedrosa M, Sepe TE, Russell RR (1995) Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. J Am Coll Nutr 14:364\u2013368","journal-title":"J Am Coll Nutr"},{"key":"2335_CR82","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1002\/jbmr.166","volume":"25","author":"KE Hansen","year":"2010","unstructured":"Hansen KE, Jones AN, Lindstrom MJ, Davis LA, Ziegler TE, Penniston KL, Alvig AL, Shafer MM (2010) Do proton pump inhibitors decrease calcium absorption? J Bone Miner Res 25:2786\u20132795","journal-title":"J Bone Miner Res"},{"key":"2335_CR83","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1620\/tjem.156.237","volume":"156","author":"M Imamura","year":"1988","unstructured":"Imamura M, Yamauchi H, Fukushima K, Sasaki I, Ouchi A (1988) Bone metabolism following gastric surgery: microdensitometry and single-photon absorptiometry. Tohoku J Exp Med 156:237\u2013249","journal-title":"Tohoku J Exp Med"},{"key":"2335_CR84","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF00235526","volume":"70","author":"H Resch","year":"1992","unstructured":"Resch H, Pietschmann P, Pernecker B, Krexner E, Willvonseder R (1992) The influence of partial gastrectomy on biochemical parameters of bone metabolism and bone density. Clin Investig 70:426\u2013429","journal-title":"Clin Investig"},{"key":"2335_CR85","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/bjs.1800790413","volume":"79","author":"K Inoue","year":"1992","unstructured":"Inoue K, Shiomi K, Higashide S, Kan N, Nio Y, Tobe T, Shigeno C, Konishi J, Okumura H, Yamamuro T et al (1992) Metabolic bone disease following gastrectomy: assessment by dual energy X-ray absorptiometry. Br J Surg 79:321\u2013324","journal-title":"Br J Surg"},{"key":"2335_CR86","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03549778","volume":"53","author":"D Mellstr\u00f6m","year":"1993","unstructured":"Mellstr\u00f6m D, Johansson C, Johnell O, Lindstedt G, Lundberg PA, Obrant K, Sch\u00f6\u00f6n IM, Toss G, Ytterberg BO (1993) Osteoporosis, metabolic aberrations, and increased risk for vertebral fractures after partial gastrectomy. Calcif Tissue Int 53:370\u2013377","journal-title":"Calcif Tissue Int"},{"key":"2335_CR87","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9610(97)00123-2","volume":"174","author":"TT Zittel","year":"1997","unstructured":"Zittel TT, Zeeb B, Maier GW, Kaiser GW, Zwirner M, Liebich H, Starlinger M, Becker HD (1997) High prevalence of bone disorders after gastrectomy. Am J Surg 174:431\u2013438","journal-title":"Am J Surg"},{"key":"2335_CR88","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1515\/CCLM.1999.114","volume":"37","author":"A Schmiedl","year":"1999","unstructured":"Schmiedl A, Schwille PO, St\u00fchler C, G\u00f6hl J, R\u00fcmenapf G (1999) Low bone mineral density after total gastrectomy in males: a preliminary report emphasizing the possible significance of urinary net acid excretion, serum gastrin and phosphorus. Clin Chem Lab Med 37:739\u2013744","journal-title":"Clin Chem Lab Med"},{"key":"2335_CR89","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s002230010025","volume":"66","author":"Y Adachi","year":"2000","unstructured":"Adachi Y, Shiota E, Matsumata T, Iso Y, Yoh R, Kitano S (2000) Osteoporosis after gastrectomy: bone mineral density of lumbar spine assessed by dual-energy X-ray absorptiometry. Calcif Tissue Int 66:119\u2013122","journal-title":"Calcif Tissue Int"},{"key":"2335_CR90","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S8756-3282(00)00404-X","volume":"28","author":"JT Heiskanen","year":"2001","unstructured":"Heiskanen JT, Kr\u00f6ger H, P\u00e4\u00e4kk\u00f6nen M, Parviainen MT, Lamberg-Allardt C, Alhava E (2001) Bone mineral metabolism after total gastrectomy. Bone 28:123\u2013127","journal-title":"Bone"},{"key":"2335_CR91","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.3748\/wjg.13.6492","volume":"13","author":"JS Lim","year":"2007","unstructured":"Lim JS, Kim SB, Bang HY, Cheon GJ, Lee JI (2007) High prevalence of osteoporosis in patients with gastric adenocarcinoma following gastrectomy. World J Gastroenterol 13:6492\u20136497","journal-title":"World J Gastroenterol"},{"key":"2335_CR92","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/gut.32.11.1303","volume":"32","author":"S Bisballe","year":"1991","unstructured":"Bisballe S, Eriksen EF, Melsen F, Mosekilde L, S\u00f8rensen OH, Hessov I (1991) Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry. Gut 32:1303\u20131307","journal-title":"Gut"},{"key":"2335_CR93","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000023499","volume":"52","author":"Z Efstathiadou","year":"1999","unstructured":"Efstathiadou Z, Bitsis S, Tsatsoulis A (1999) Gastrectomy and osteomalacia: an association not to be forgotten. Horm Res 52:295\u2013297","journal-title":"Horm Res"},{"key":"2335_CR94","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0115426507022003286","volume":"22","author":"DA Straub","year":"2007","unstructured":"Straub DA (2007) Calcium supplementation in clinical practice: a review of forms, doses, and indications. Nutr Clin Pract 22:286\u2013296","journal-title":"Nutr Clin Pract"},{"key":"2335_CR95","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1177\/009127009903901106","volume":"39","author":"HJ Heller","year":"1999","unstructured":"Heller HJ, Stewart A, Haynes S, Pak CY (1999) Pharmacokinetics of calcium absorption from two commercial calcium supplements. J Clin Pharmacol 39:1151\u20131154","journal-title":"J Clin Pharmacol"},{"key":"2335_CR96","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/07315724.2001.10719038","volume":"20","author":"RP Heaney","year":"2001","unstructured":"Heaney RP, Dowell MS, Bierman J, Hale CA, Bendich A (2001) Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr 20:239\u2013246","journal-title":"J Am Coll Nutr"},{"key":"2335_CR97","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00198-003-1567-0","volume":"15","author":"AM Kenny","year":"2004","unstructured":"Kenny AM, Prestwood KM, Biskup B, Robbins B, Zayas E, Kleppinger A, Burleson JA, Raisz LG (2004) Comparison of the effects of calcium loading with calcium citrate or calcium carbonate on bone turnover in postmenopausal women. Osteoporos Int 15:290\u2013294","journal-title":"Osteoporos Int"},{"key":"2335_CR98","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1503\/cmaj.071330","volume":"179","author":"LE Targownik","year":"2008","unstructured":"Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD (2008) Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ 179:319\u2013326","journal-title":"CMAJ"},{"key":"2335_CR99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00223-008-9188-4","volume":"84","author":"C Roux","year":"2009","unstructured":"Roux C, Briot K, Gossec L, Kolta S, Blenk T, Felsenberg D, Reid DM, Eastell R, Gl\u00fcer CC (2009) Increase in vertebral fracture risk in postmenopausal women using omeprazole. Calcif Tissue Int 84:13\u201319","journal-title":"Calcif Tissue Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2335-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-013-2335-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2335-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T16:41:22Z","timestamp":1688143282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-013-2335-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,28]]},"references-count":99,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["2335"],"URL":"https:\/\/doi.org\/10.1007\/s00198-013-2335-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,28]]}}}